Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
OS Therapies Incorporated (OSTX) had Consolidated Net Income/Loss of $-10.40M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-10.40M |
|
-- |
|
-- |
|
$10.17M |
|
$-10.17M |
|
$-0.23M |
|
$-10.40M |
|
$-10.40M |
|
$-10.40M |
|
$-10.40M |
|
|
Consolidated Net Income/Loss |
$-10.40M |
$-10.40M |
|
$-10.17M |
|
$-9.97M |
|
38.67M |
|
38.67M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$0.92M |
|
$0.00M |
|
$6.38M |
|
$7.30M |
|
$16.95M |
|
-- |
|
$0.10M |
|
$17.05M |
|
$-10.82M |
|
$-16.13M |
|
$-9.75M |
|
39.28M |
|
| Cash Flow Statement Financials | |
$-4.56M |
|
-- |
|
$5.21M |
|
$0.27M |
|
$0.92M |
|
$0.65M |
|
$1.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.05% |
|
64.44% |
|
-142.44% |
|
106.60% |
|
$-0.25 |
|
$-0.12 |
|
$-0.12 |
|